|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used in) operating activities | |||||
| Net income (loss) for the year | |||||
| Adjustments to reconcile profit (loss) | |||||
| Depreciation, depletion and amortization | |||||
| Depreciation, right-of-use assets | |||||
| Interest expense on lease liabilities | |||||
| Result from sale and disposal of property, plant and equipment, intangible and biological assets, net | |||||
| Income (expense) from associates and joint ventures | |||||
| Exchange rate and monetary variations, net | |||||
| Interest expenses on financing, loans and debentures | |||||
| Adjustments for finance costs | |||||
| Accrual of interest on marketable securities | |||||
| Amortization of transaction costs, premium and discounts | |||||
| Derivative financial instruments, net | |||||
| Gain on fair value adjustments (Note 29) | |||||
| Deferred income tax and social contribution | |||||
| Interest on actuarial liabilities and cost of current service | |||||
| Provision for judicial liabilities, net | |||||
| Provision (reversal) for doubtful accounts, net | |||||
| Provision (reversal) for inventory losses, net | |||||
| Provision (reversal) for loss of ICMS credits, net | |||||
| Tax credits | |||||
| Premium expenses on early settlements | |||||
| Other | |||||
| Trade accounts receivable | |||||
| Inventories | |||||
| Recoverable taxes | |||||
| Other assets | |||||
| Trade accounts payable | |||||
| Taxes payable | |||||
| Payroll and charges | |||||
| Other liabilities | |||||
| Cash generated from operations | |||||
| Payment of interest on financing, loans and debentures | |||||
| Adjustment for operating costs | |||||
| Capitalized loan costs paid | |||||
| Premium expenses on early settlements paid | |||||
| Interest received on marketable securities | |||||
| Payment of income taxes | |||||
| Cash provided by operating activities | |||||
| Additions to property, plant and equipment | |||||
| Additions to intangible | |||||
| Purchase of biological assets | |||||
| Proceeds from sales of property, plant and equipment and biological assets | |||||
| Capital increase in affiliates | |||||
| Marketable securities, net | |||||
| Advances for acquisition of wood from operations with development and partnerships | |||||
| Dividends received | |||||
| Asset acquisition | |||||
| Acquisition of subsidiaries | |||||
| Acquisition of other investments | |||||
| Net cash from acquisition of subsidiaries | |||||
| Cash used in investing activities | |||||
| Proceeds from loans, financing and debentures | |||||
| Proceeds from derivative transactions | |||||
| Payment of loans, financing and debentures | |||||
| Payment of leases | |||||
| Payment of interest on own capital and dividends | |||||
| Liabilities for assets acquisitions and subsidiaries | |||||
| Shares repurchased | |||||
| Cash used by financing activities | |||||
| EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS | |||||
| Increase (Decrease) in cash and cash equivalents, net | |||||
| At the beginning of the year | |||||
| At the end of the year | |||||
Loading...
